Bradley Elizabeth H, Herrin Jeph, Wang Yongfei, McNamara Robert L, Radford Martha J, Magid David J, Canto John G, Blaney Martha, Krumholz Harlan M
Division of Health Policy and Administration, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520-8088, USA.
Am Heart J. 2006 Jun;151(6):1281-7. doi: 10.1016/j.ahj.2005.07.015.
To better understand hospital performance in door-to-drug and door-to-balloon times for patients with STEMI, we examined hospital-level variation in key subintervals of door-to-drug time (door-to-electrocardiogram [ECG] and ECG-to-drug) and of door-to-balloon time (door-to-ECG, ECG-to-lab, lab-to-balloon). We sought to identify achievable subinterval times based on the experience of top performing hospitals.
We conducted a cross-sectional analysis, using data from the National Registry of Myocardial Infarction, of admissions between January 1, 2001, and December 31, 2002 (20435 patients receiving fibrinolytic therapy in 693 hospitals, and 13387 patients receiving percutaneous coronary intervention in 340 hospitals). Using hierarchical regression modeling, we estimated hospital-level geometric means of each subinterval, adjusted for patient clinical characteristics. We ranked hospitals based on the proportion of patients treated within 30 minutes for door-to-drug time and 90 minutes for door-to-balloon times and compared adjusted subinterval times across these groups.
The higher performing hospitals (top 20%) in door-to-drug time and door-to-balloon times had significantly shorter times in nearly all subintervals compared with other hospitals, adjusted for patient clinical characteristics. Adjusted mean subinterval times in higher performing hospitals in door-to-drug time were 6.8 minutes (SD = 1.7) for door-to-ECG and 18.7 minutes (SD = 3.5) for ECG-to-drug. Adjusted mean subinterval times in higher performing hospitals in door-to-balloon time were 7.9 minutes (SD = 1.7) for door-to-ECG, 47.8 minutes (SD = 7.1) for ECG-to-lab, and 29.0 minutes (5.4) for lab-to-balloon, adjusted for patient clinical characteristics.
Substantial national attention is being directed at improving time to treatment of patients with STEMI. These data suggest achievable subinterval times for hospitals seeking to improve performance in this important quality indicator.
为了更好地了解ST段抬高型心肌梗死(STEMI)患者从入院到用药及从入院到球囊扩张的医院表现,我们研究了医院层面在从入院到用药时间(从入院到心电图[ECG]及从心电图到用药)和从入院到球囊扩张时间(从入院到心电图、从心电图到实验室检查、从实验室检查到球囊扩张)的关键子区间的差异。我们试图根据表现最佳的医院的经验确定可实现的子区间时间。
我们利用国家心肌梗死注册中心的数据进行了一项横断面分析,纳入2001年1月1日至2002年12月31日期间的住院患者(693家医院的20435例接受溶栓治疗的患者,以及340家医院的13387例接受经皮冠状动脉介入治疗的患者)。使用分层回归模型,我们估计了每个子区间的医院层面几何均数,并根据患者临床特征进行了调整。我们根据在30分钟内完成从入院到用药时间及在90分钟内完成从入院到球囊扩张时间的患者比例对医院进行排名,并比较这些组间调整后的子区间时间。
在从入院到用药时间和从入院到球囊扩张时间方面表现较好的医院(前20%),在几乎所有子区间中,经患者临床特征调整后,时间显著短于其他医院。在从入院到用药时间方面表现较好的医院,调整后的从入院到心电图平均子区间时间为6.8分钟(标准差=1.7),从心电图到用药为18.7分钟(标准差=3.5)。在从入院到球囊扩张时间方面表现较好的医院,调整后的从入院到心电图平均子区间时间为7.9分钟(标准差=1.7),从心电图到实验室检查为47.8分钟(标准差=7.1),从实验室检查到球囊扩张为29.0分钟(标准差=5.4),均经患者临床特征调整。
国家正大力关注改善STEMI患者的治疗时间。这些数据表明,对于寻求改善这一重要质量指标表现的医院,子区间时间是可以实现的。